Siga Technologies (SIGA) EBIT Margin Growth (3y) (2013 - 2025)

Siga Technologies (SIGA) EBIT Margin Growth (3y) (2013 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Margin Growth (3y) (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 1,673.00
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn -37.00
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn -5,395.00
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn -1,442.00
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn -1,299.00
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 5,091.00
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 5,193.00
10 Siga Technologies 225.56 Mn 70.59 Mn - -

Historic Data

Download Data
DateValue
Sep 30, 2025 -44,955.00
Jun 30, 2025 3,789.00
Mar 31, 2025 -1,838.00
Dec 31, 2024 -1,144.00
Sep 30, 2024 6,616.00
Jun 30, 2024 494.00
Mar 31, 2024 8,567.00
Dec 31, 2023 766.00
Sep 30, 2023 -8,850.00
Jun 30, 2023 -15,028.00
Mar 31, 2023 12,728.00
Dec 31, 2022 6,549.00
Sep 30, 2022 5,123.00
Jun 30, 2022 6,206.00
Mar 31, 2022 -3,461.00
Dec 31, 2021 43,466.00
Sep 30, 2021 -13,905.00
Jun 30, 2021 13,943.00
Mar 31, 2021 21,811.00
Dec 31, 2020 41,601.00